Last deal

$100K

Amount

Grant

Stage

14.12.2022

Date

5

all rounds

$4.9M

Total amount

General

About Company
Immuto Scientific provides biotechnology services to pharmaceutical companies for drug discovery.

Industry

Sector :

Subsector :

founded date

01.08.2018

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company's protein footprinting technology automates complex protein analysis, providing fast, high-resolution structural characterization of therapeutic proteins and antibodies in their native form. This accelerates the lead validation process of drug development, making it faster than the industry gold standard technique for protein structure analysis. Immuto Scientific is a CRO specializing in protein characterization services, serving the pharmaceutical industry with patented technology.
Contacts

Phone number

Social url